A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. - Wikidata - awgldk - TriplyDB

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

http://www.wikidata.org/entity/Q40099109

about

Relevance of tumor-infiltrating lymphocytes in breast cancer Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy Myeloid-derived suppressor cells as regulators of the immune system Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity.Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette.Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.Innate immunity mediated by MyD88 signal is not essential for induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection.Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Tumor antigen cross-presentation and the dendritic cell: where it all begins?L-BLP25 as a peptide vaccine therapy in non-small cell lung cancer: a review.Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens.Optimizing dendritic cell-based approaches for cancer immunotherapy Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation.The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells.Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.Bone-immune cell crosstalk: bone diseases.A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer.Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy.Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer.Compensatory roles of CD8+ T cells and plasmacytoid dendritic cells in gut immune regulation for reduced function of CD4+ Tregs

P2860

Q26795598-7E031101-7FC9-496E-A89C-CA0CE1070748 Q27002646-0A00E68D-CD95-46E8-8065-47CC0814607A Q27027093-D4EEE196-6095-4AF3-89CE-447B7E152512 Q27686800-28680B09-004E-41A5-A439-4F96DABBD9B6 Q28082461-032854A3-ABFE-4437-B89F-37A0D5F18BCA Q28131637-EE06EEB2-DF97-4B49-A999-7A06C178125B Q28384980-D7269945-B618-45B1-8C74-16DE561E6997 Q28485258-937187C3-4484-4143-BE38-796E7FED4913 Q30240816-854D0959-8F43-48C5-8CDA-65CF2AECDB94 Q30584571-6DC7D440-45A7-4D66-A5A6-5448E6851905 Q33514120-E8DF799D-70AC-403D-995E-5B234A344F07 Q33604484-71F1971D-8318-4B1A-ACA5-25C6B653F395 Q33606107-61A2DB3D-0648-41DC-BBE0-F2BBC8A49B8C Q33653210-A07E890A-BCD6-4C84-9E1D-3D8CC345B1B2 Q33723063-F61B45B2-6560-4D97-A1B1-DBBA14DEFE16 Q33725490-51F585C4-B1DF-4069-8E4B-29B09DFCC100 Q33733198-911FDA0F-281C-40B9-828C-002F4DD91629 Q34210664-413BE482-6EEA-4CED-A742-A174304FC482 Q34430511-B6238694-5F4F-494F-A66E-0B4F888C939E Q34634220-4926CF82-0054-48E9-9EFB-4D1BBF0DD219 Q34637535-86055322-43AF-4BAB-83C9-30684C715038 Q34653776-1A42E4E1-8E72-4512-8047-6304428A81F0 Q34808155-D6B95F5C-8D13-4CEF-9A0B-58A9B67BB995 Q34877332-019B9B27-2A5F-4B9A-8EAC-31ECC639A1D2 Q35067983-1E0F4EAB-B16E-48F3-8313-7699F4D18CFE Q35141469-C11E724E-E14B-4C2D-BB82-14D5339EAA1E Q35207756-74C4EDFF-0E7E-4752-A9C4-59671E3E90B9 Q35227738-B5C9149C-2811-4262-958D-A0817E7F1FCF Q35592362-1532C664-62CF-443B-B378-20F17B134946 Q36106412-6C96125B-B97C-413D-9175-80E56DBC0B4C Q36272860-7D9924A2-79B0-43A0-961D-20CF4A369B8C Q36277369-E12F97E0-2E01-4E1D-9794-1C688A304A33 Q36414429-3B545A12-B5C2-458F-B3C2-B032A1FC421A Q36512169-391773D4-BC02-44F1-AE83-6C7012D83659 Q36625312-60E78096-5B61-4EFB-BB3E-5133F6802193 Q36664213-64D28787-BEF4-4F96-90DC-84ABB8481FD0 Q36796146-E2A8D6D2-31DB-4171-BA86-72D2B6B67B47 Q36896764-763FFB0A-A0F9-4F19-893E-33F8CD8D6C90 Q36981678-7013C6E2-6258-4E6B-B5EC-3472137CF1BE Q36998133-B3C5087B-7EEB-4042-A9CA-B7238D2BAC15

P2860

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

http://www.wikidata.org/entity/Q40099109

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

A combination of chemoimmunoth ...... olerogenic murine tumor model.

@en

type

label

A combination of chemoimmunoth ...... olerogenic murine tumor model.

@en

prefLabel

A combination of chemoimmunoth ...... olerogenic murine tumor model.

@en

P1433

Q40099109-57481AB2-93AC-4932-A768-D00501EF13F5

P1476

Q40099109-DE7B4293-75A5-42E2-87B7-0946C70AAB3C

P2093

Q40099109-0085AD78-BABD-4E29-84FB-277E78CF9A13

Q40099109-5AC94021-B422-4E51-9D76-C4265E2A45ED

Q40099109-68CFCFE9-B091-4689-B37D-24EA1113532B

Q40099109-7B1F1838-28EF-4467-8185-FFE2F8767DF8

Q40099109-7F7FCE04-1ED6-4FFA-8FF3-EE7426816025

Q40099109-85C0FF49-4D58-4AE4-A201-E7E2A8154D55

Q40099109-EF0BD284-33DE-422E-8257-E4A7698F05D4

Q40099109-F6486640-029D-44FB-94E6-AF984D5CF072

P304

Q40099109-EDC49AF1-B98D-441D-954C-AB281294D154

P31

Q40099109-BFB6DD4A-A33A-43A3-9CE7-E11D2CD355C6

P356

Q40099109-7B4D49B8-D8CB-49DE-BF69-D967D76270D9

P407

Q40099109-D9DE6B4E-F7F9-4737-BA27-D6A873FA51F1

P433

Q40099109-66E74053-9BF9-4FE7-A04D-4DF6730868C5

P478

Q40099109-28837241-7D80-412A-8966-5F5CB5DB87BB

P577

Q40099109-4B390160-367A-4D3C-AB70-3EC166410460

P698

Q40099109-6BD40C3F-DB4E-4E32-92ED-B7FEBD8EE462

P356

0008-5472.CAN-06-4639

P1433

Cancer Research

P1476

A combination of chemoimmunoth ...... olerogenic murine tumor model.

@en

P2093

Chang-Yuil Kang

http://www.w3.org/2001/XMLSchema#string

Hyun-Jeong Ko

http://www.w3.org/2001/XMLSchema#string

Shimon Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Sun-Young Chang

http://www.w3.org/2001/XMLSchema#string

Sung-Youl Ko

http://www.w3.org/2001/XMLSchema#string

Woo-Sung Chang

http://www.w3.org/2001/XMLSchema#string

Yeon-Jeong Kim

http://www.w3.org/2001/XMLSchema#string

Yun-Sun Kim

http://www.w3.org/2001/XMLSchema#string

P304

7477-7486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-06-4639

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17671218

http://www.w3.org/2001/XMLSchema#string